[PDF][PDF] Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway

D Homann, A Holz, A Bot, B Coon, T Wolfe, J Petersen… - Immunity, 1999 - cell.com
D Homann, A Holz, A Bot, B Coon, T Wolfe, J Petersen, TP Dyrberg, MJ Grusby…
Immunity, 1999cell.com
Targeted immune regulation can be achieved by use of tissue-specific T cells and offers the
potential for organ-specific suppression of destructive autoimmune processes. Here, we
report the generation and characterization of insulin B chain–specific" autoreactive" CD4+
regulatory T cells that locally suppress diabetogenic T cell responses against an unrelated
self-antigen (viral transgene) in a virus-induced model for type 1 diabetes. Interleukin 4 (IL-
4) is essential for prevention of diabetes since regulatory T cells cannot be induced in the …
Abstract
Targeted immune regulation can be achieved by use of tissue-specific T cells and offers the potential for organ-specific suppression of destructive autoimmune processes. Here, we report the generation and characterization of insulin B chain–specific "autoreactive" CD4+ regulatory T cells that locally suppress diabetogenic T cell responses against an unrelated self-antigen (viral transgene) in a virus-induced model for type 1 diabetes. Interleukin 4 (IL-4) is essential for prevention of diabetes since regulatory T cells cannot be induced in the absence of IL-4 or stat6 (IL-4 signaling pathway). Our observations demonstrate that autoreactive regulatory T cells can suppress autoreactive destructive T cell activity of differential antigenic specificity locally in the pancreatic draining lymph node, probably via cytokine-mediated modulation of antigen-presenting cells.
cell.com